Browsing: reimbursement

Pharming’s Joenja, a treatment for APDS, has been approved for reimbursement in England after NICE reversed its earlier rejection. The EU regulatory review is still ongoing.

This article explores the common obstacles hindering the progress of health tech products and provides insights on how to overcome these barriers and achieve market success.